




Searching News Database: pharmacological chaperone
HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
HSMN NewsFeed - 27 Apr 2015
Amicus Therapeutics Appoints David Allsop as Senior Vice President, International
Amicus Therapeutics Appoints David Allsop as Senior Vice President, International
HSMN NewsFeed - 20 Aug 2014
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
HSMN NewsFeed - 10 Sep 2013
Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease
Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease
HSMN NewsFeed - 29 Jun 2011
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
HSMN NewsFeed - 5 Mar 2007
Amicus Therapeutics Announces Return of John F. Crowley as President and Chief Executive Officer
Amicus Therapeutics Announces Return of John F. Crowley as President and Chief Executive Officer
HSMN NewsFeed - 23 Jan 2007
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
HSMN NewsFeed - 14 Sep 2006
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Additional items found! 3

Members Archive contains
3 additional stories matching:
pharmacological chaperone
(Password required)
pharmacological chaperone
(Password required)